NCT02797184View on ClinicalTrials.gov

Inorganic NItrate and EXercise Performance in Heart Failure (iNIX-HF): Dose Response

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2017

Primary Completion Date

October 31, 2021

Study Completion Date

December 15, 2021

Conditions

Heart Failure

Interventions

DRUG

KNO3, potassium nitrate

Potassium nitrate (KNO3) will be given orally in 2 gelatin capsules, which will be compounded by the Barnes-Jewish Hospital Pharmacy. The doses are 10 mmol and 20 mmol KNO3.

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors

lead

Washington University School of Medicine

OTHER

NCT02797184 - Inorganic NItrate and EXercise Performance in Heart Failure (iNIX-HF): Dose Response | Biotech Hunter | Biotech Hunter